Increased urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG)/creatinine level is associated with the progression of normal-tension glaucoma

Current Eye Research

Volumn 38, Issue 9, 2013, Pages 983-988

  Yuki, Kenya ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

8 Hydroxy 2 deoxyguanosine; Normal tension glaucoma; Oxidative DNA damage; Oxidative stress; Visual field progression

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CREATININE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREATININE URINE LEVEL; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; URINALYSIS; VISUAL FIELD;

ADULT; AGED; BIOLOGICAL MARKERS; CREATININE; DEOXYADENOSINES; DISEASE PROGRESSION; DNA DAMAGE; FEMALE; HUMANS; INTRAOCULAR PRESSURE; LOW TENSION GLAUCOMA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; VISUAL FIELDS;

EID: 84880908127     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.800889     Document Type: Article

References (41)

1. Quigley HA. Glaucoma. Lancet 2011;377:1367-1377.
2. Shields MB. Normal-tension glaucoma: Is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 2008;19:85-88.
3. Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: The Tajimi Study. Ophthalmology 2004;111: 1641-1648.
4. Yuki K, Ozawa Y, Yoshida T, Kurihara T, Hirasawa M, Ozeki N, et al. Retinal ganglion cell loss in superoxide dismutase 1 deficiency. Invest Ophthalmol Vis Sci 2011;52: 4143-4150.
5. Harada T, Harada C, Nakamura K, Quah HM, Okumura A, Namekata K, et al. The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. J Clin Invest 2007;117:1763-1770.
6. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004; 339:1-9.
7. Valavanidis A, Vlachogianni T, Fiotakis C. 8-Hydroxy-20- deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009;27:120-139.
8. Masugata H, Senda S, Murao K, Inukai M, Himoto T, Hosomi N, et al. Association between urinary 8-hydroxydeoxyguanosine, an indicator of oxidative stress, and the cardio-ankle vascular index in hypertensive patients. J Atheroscler Thromb 2012;19:747-755.
9. Loft S, Fischer-Nielsen A, Jeding IB, Vistisen K, Poulsen HE. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health 1993;40: 391-404.
10. Loft S, Poulsen HE. Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim Pol 1998;45:133-144.
11. Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy- 20-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci 1989;86: 9697-9701.
12. Fam SS, Morrow JD. The isoprostanes: Unique products of arachidonic acid oxidation - a review. Curr Med Chem 2003;10:1723-1740.
13. Morrow JD, Zackert WE, Yang JP, Kurhts EH, Callewaert D, Dworski R, et al. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem 1999;269:326-331.
14. Ozden H, Kabay SC, Toker A, Ustuner MC, Ozbayer C, Ustuner D, et al. The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients. Seizure 2010; 19:514-516.
15. Nonaka-Sarukawa M, Yamamoto K, Aoki H, Takano H, Katsuki T, Ikeda U, et al. Increased urinary 15-F2tisoprostane concentrations in patients with non-ischaemic congestive heart failure: A marker of oxidative stress. Heart 2003;89:871-874.
16. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000;28:505-513.
17. Yuki K, Murat D, Kimura I, Tsubota K. Increased serum total antioxidant status and decreased urinary 8-hydroxy- 20-deoxyguanosine levels in patients with normal-tension glaucoma. Acta Ophthalmol 2010;88:259-264.
18. Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normaltension glaucoma. Jpn J Ophthalmol 2004;48:380-385.
19. Nouri-Mahdavi K, Hoffman D, Ralli M, Caprioli J. Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol 2007;125:1176-1181.
20. Sorkhabi R, Ghorbanihaghjo A, Javadzadeh A, Rashtchizadeh N, Moharrery M. Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol Vis 2011;17:41-46.
21. Aslan M, Cort A, Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic Biol Med 2008;45: 367-376.
22. Tezel G. Oxidative stress in glaucomatous neurodegeneration: Mechanisms and consequences. Prog Retin Eye Res 2006;25:490-513.
23. Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res 2006;612:105-114.
24. Erdurmus M, Yagci R, Atis O, Karadag R, Akbas A, Hepsen IF. Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr Eye Res 2011;36:713-718.
25. McElnea EM, Quill B, Docherty NG, Irnaten M, Siah WF, Clark AF, et al. Oxidative stress, mitochondrial dysfunction and calcium overload in human lamina cribrosa cells from glaucoma donors. Mol Vis 2011;17:1182-1191.
26. Engin KN, Yemisci B, Yigit U, Agachan A, Coskun C. Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol Vis 2010;16:1260-1271.
27. Ferreira SM, Lerner SF, Brunzini R, Evelson PA. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol 2004;137:62-69.
28. Ghanem AA, Arafa LF, El-Baz A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr Eye Res 2010;35:295-301.
29. Feilchenfeld Z, Yucel YH, Gupta N. Oxidative injury to blood vessels and glia of the pre-laminar optic nerve head in human glaucoma. Exp Eye Res 2008;87:409-414.
30. Zanon-Moreno V, Marco-Ventura P, Lleo-Perez A, Pons- Vazquez S, Garcia-Medina JJ, Vinuesa-Silva I, et al. Oxidative stress in primary open-angle glaucoma. J Glaucoma 2008;17:263-268.
31. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2005;46:877-883.
32. Sacca SC, Pascotto A, Camicione P, Capris P, Izzotti A. Oxidative DNA damage in the human trabecular meshwork: Clinical correlation in patients with primary openangle glaucoma. Arch Ophthalmol 2005;123:458-463.
33. Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med 2003;114:638-646.
34. Izzotti A, Sacca SC, Longobardi M, Cartiglia C. Mitochondrial damage in the trabecular meshwork of patients with glaucoma. Arch Ophthalmol 2011;128: 724-730.
35. Szaflik JP, Rusin P, Zaleska-Zmijewska A, Kowalski M, Majsterek I, Szaflik J. Reactive oxygen species promote localized DNA damage in glaucoma-iris tissues of elderly patients vulnerable to diabetic injury. Mutat Res 2010;697: 19-23.
36. Yuki K, Murat D, Kimura I, Ohtake Y, Tsubota K. Reducedserum vitamin C and increased uric acid levels in normaltension glaucoma. Graefes Arch Clin Exp Ophthalmol 2009;248:243-248.
37. Obrenovitch TP. Molecular physiology of preconditioninginduced brain tolerance to ischemia. Physiol Rev 2008;88: 211-247.
38. Yang Z, Quigley HA, Pease ME, Yang Y, Qian J, Valenta D, et al. Changes in gene expression in experimental glaucoma and optic nerve transaction: The equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci 2007;48:5539-5548.
39. Quigley HA. Can diabetes be good for glaucoma? Why can't we believe our own eyes (or data)? Arch Ophthalmol 2009;127:227-229.
40. Oh SW, Lee S, Park C, Kim DJ. Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev 2005;21: 434-440.
41. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444-445.